Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

795 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
Pfaffendorf C, Vonthein R, Krockenberger-Ziegler K, Dellas K, Schreiber A, Uhlemann D, Dinges S, Würschmidt F, Andreas P, Weinstrauch E, Eilf K, Rades D, Höller U, Combs SE, Kazmierczak R, Fehlauer F, Schreck U, Zimmer J, Dunst J, Krug D. Pfaffendorf C, et al. Among authors: zimmer j. Breast. 2022 Aug;64:136-142. doi: 10.1016/j.breast.2022.05.008. Epub 2022 Jun 2. Breast. 2022. PMID: 35691249 Free PMC article. Clinical Trial.
Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phase II trial (ARO-2010-01).
Dellas K, Vonthein R, Zimmer J, Dinges S, Boicev AD, Andreas P, Fischer D, Winkler C, Ziegler A, Dunst J; ARO Study Group. Dellas K, et al. Among authors: zimmer j. Strahlenther Onkol. 2014 Jul;190(7):646-53. doi: 10.1007/s00066-014-0658-5. Epub 2014 Apr 16. Strahlenther Onkol. 2014. PMID: 24737540 Clinical Trial.
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D, Baumann R, Krockenberger K, Vonthein R, Schreiber A, Boicev A, Würschmidt F, Weinstrauch E, Eilf K, Andreas P, Höller U, Dinges S, Piefel K, Zimmer J, Dellas K, Dunst J. Krug D, et al. Among authors: zimmer j. Strahlenther Onkol. 2021 Jan;197(1):48-55. doi: 10.1007/s00066-020-01689-7. Epub 2020 Oct 1. Strahlenther Onkol. 2021. PMID: 33001241 Free PMC article. Clinical Trial.
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial.
Krug D, Vonthein R, Schreiber A, Boicev AD, Zimmer J, Laubach R, Weidner N, Dinges S, Hipp M, Schneider R, Weinstrauch E, Martin T, Hörner-Rieber J, Olbrich D, Illen A, Heßler N, König IR, Dellas K, Dunst J. Krug D, et al. Among authors: zimmer j. Strahlenther Onkol. 2021 Sep;197(9):802-811. doi: 10.1007/s00066-020-01730-9. Epub 2020 Dec 15. Strahlenther Onkol. 2021. PMID: 33320286 Free PMC article. Clinical Trial.
Glycosyl transferase GT2 genes mediate the biosynthesis of an unusual (1,3;1,4)-β-glucan exopolysaccharide in the bacterium Sarcina ventriculi.
Lampugnani ER, Ford K, Ho YY, van de Meene A, Lahnstein J, Tan HT, Burton RA, Fincher GB, Shafee T, Bacic A, Zimmer J, Xing X, Bulone V, Doblin MS, Roberts EM. Lampugnani ER, et al. Among authors: zimmer j. Mol Microbiol. 2024 May 15. doi: 10.1111/mmi.15276. Online ahead of print. Mol Microbiol. 2024. PMID: 38750617
795 results